Acinar to β-like cell conversion through inhibition of focal adhesion kinase.
Shakti DahiyaMohamed SalehUylissa A RodriguezDhivyaa RajasundaramJorge R ArbujasArian HajihassaniKaiyuan YangAnuradha SehrawatRanjeet KalsiShiho YoshidaKrishna PrasadanHeiko LickertJing HuJon D PiganelliGeorge K GittesFarzad EsniPublished in: Nature communications (2024)
Insufficient functional β-cell mass causes diabetes; however, an effective cell replacement therapy for curing diabetes is currently not available. Reprogramming of acinar cells toward functional insulin-producing cells would offer an abundant and autologous source of insulin-producing cells. Our lineage tracing studies along with transcriptomic characterization demonstrate that treatment of adult mice with a small molecule that specifically inhibits kinase activity of focal adhesion kinase results in trans-differentiation of a subset of peri-islet acinar cells into insulin producing β-like cells. The acinar-derived insulin-producing cells infiltrate the pre-existing endocrine islets, partially restore β-cell mass, and significantly improve glucose homeostasis in diabetic mice. These findings provide evidence that inhibition of the kinase activity of focal adhesion kinase can convert acinar cells into insulin-producing cells and could offer a promising strategy for treating diabetes.
Keyphrases
- induced apoptosis
- type diabetes
- cell cycle arrest
- single cell
- small molecule
- glycemic control
- cardiovascular disease
- endoplasmic reticulum stress
- cell therapy
- escherichia coli
- tyrosine kinase
- cell death
- signaling pathway
- staphylococcus aureus
- adipose tissue
- cell proliferation
- blood pressure
- rna seq
- pi k akt
- insulin resistance
- combination therapy